Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 21, Pages 13466
Publisher
MDPI AG
Online
2022-11-04
DOI
10.3390/ijms232113466
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blood GFAP as an emerging biomarker in brain and spinal cord disorders
- (2022) Ahmed Abdelhak et al. Nature Reviews Neurology
- Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4
- (2022) Christoph Kessler et al. Annals of Clinical and Translational Neurology
- Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
- (2022) Pascal Benkert et al. LANCET NEUROLOGY
- Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia
- (2021) Christoph Kessler et al. Annals of Clinical and Translational Neurology
- A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis
- (2021) Martina Absinta et al. NATURE
- NfL and pNfH are increased in Friedreich’s ataxia
- (2020) Stefanie Nicole Hayer et al. JOURNAL OF NEUROLOGY
- Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice
- (2020) Carlo Wilke et al. EMBO Molecular Medicine
- Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
- (2020) Xavier Ayrignac et al. Scientific Reports
- Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
- (2019) Hans Lassmann Frontiers in Immunology
- Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
- (2019) Ahmed Abdelhak et al. Frontiers in Neurology
- Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
- (2019) Jens Kuhle et al. NEUROLOGY
- Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
- (2019) Benjamin Turner et al. JOURNAL OF NEUROLOGY
- Neurofilament light chain as a biomarker in neurological disorders
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
- (2018) Christian Barro et al. BRAIN
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Serum neurofilament light chain is increased in hereditary spastic paraplegias
- (2018) Carlo Wilke et al. Annals of Clinical and Translational Neurology
- Astrocytes play a crucial role in the formation and evolution of MS lesions – Yes
- (2018) David Pitt et al. Multiple Sclerosis Journal
- Serum GFAP as a biomarker for disease severity in multiple sclerosis
- (2018) A. Abdelhak et al. Scientific Reports
- Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
- (2018) Heidi Högel et al. Multiple Sclerosis Journal
- CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration
- (2018) Marc Pawlitzki et al. Frontiers in Neurology
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- CSF profile in primary progressive multiple sclerosis: Re-exploring the basics
- (2017) Ahmed Abdelhak et al. PLoS One
- Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients
- (2016) Rebecca Schüle et al. ANNALS OF NEUROLOGY
- Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons
- (2014) S. Havlicek et al. HUMAN MOLECULAR GENETICS
- Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
- (2014) Lior Mayo et al. NATURE MEDICINE
- Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
- (2010) M. Axelsson et al. JOURNAL OF NEUROLOGY
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now